Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
about
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patientsGenetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old.Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update.Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.Expression of p27(Kip1) and p18(Ink4c) in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors.Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.
P2860
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
@ast
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
@en
type
label
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
@ast
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
@en
prefLabel
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
@ast
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
@en
P2093
P2860
P50
P356
P1476
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1
@en
P2093
Annamaria Colao
Antongiulio Faggiano
Concetta Sciammarella
Daniela Pasquali
Francesca Marciello
Luisa Circelli
Multidisciplinary Group for NeuroEndocrine Tumours of Naples
Valeria Ramundo
Vittorio Colantuoni
P2860
P304
P356
10.1111/JCMM.12552
P577
2015-03-30T00:00:00Z